Related Experiment Video
Updated: Jun 13, 2025

A Method for Mouse Pancreatic Islet Isolation and Intracellular cAMP Determination
Published on: June 25, 2014
cNPAS2 induced β cell dysfunction by regulating KANK1 expression in type 2 diabetes
Yan-Bin Yin1, Wei Ji2, Ying-Lan Liu3
1Department of General Surgery, The First Affiliated Hospital of Jiamusi University, Jiamusi 154000, Heilongjiang Province, China.
Background:
Diabetes mellitus type 2 (T2DM) is formed by defective insulin secretion with the addition of peripheral tissue resistance of insulin action. It has been affecting over 400 million people all over the world.
Aim:
To explore the pathogenesis of T2DM and to develop and implement new prevention and treatment strategies for T2DM.
Methods:
Receiver operating characteristic (ROC) curve analysis was used to conduct diagnostic markers. The expression level of genes was determined by reverse transcription-PCR as well as Western blot. Cell proliferation assays were performed by cell counting kit-8 (CCK-8) tests. At last, T2DM mice underwent Roux-en-Y gastric bypass surgery.
Results:
We found that NPAS2 was significantly up-regulated in islet β cell apoptosis of T2DM. The ROC curve revealed that NPAS2 was capable of accurately diagnosing T2DM. NPAS2 overexpression did increase the level of KANK1. In addition, the CCK-8 test revealed knocking down NPAS2 and KANK1 increased the proliferation of MIN6 cells. At last, we found that gastric bypass may treat type 2 diabetes by down-regulating NPAS2 and KANK1.
Conclusion:
This study demonstrated that NPAS2 induced β cell dysfunction by regulating KANK1 expression in type 2 diabetes, and it may be an underlying therapy target of T2DM.
Insights
NPAS2 gene up-regulation causes islet beta cell dysfunction in type 2 diabetes (T2DM). Targeting NPAS2 and KANK1 may offer new T2DM treatment strategies, potentially through gastric bypass surgery.
Area of Science:
- Endocrinology and Metabolism
- Molecular Biology
- Genetics
Background:
- Type 2 Diabetes Mellitus (T2DM) affects over 400 million globally, characterized by impaired insulin secretion and insulin resistance.
- Understanding the molecular mechanisms of T2DM pathogenesis is crucial for developing effective interventions.
Purpose of the Study:
- To investigate the role of NPAS2 in T2DM pathogenesis.
- To explore NPAS2 as a diagnostic marker for T2DM.
- To evaluate the therapeutic potential of targeting NPAS2 and KANK1 in T2DM.
Main Methods:
- Gene expression analysis using RT-PCR and Western blot.
- Diagnostic marker evaluation via Receiver Operating Characteristic (ROC) curve analysis.
- Cell proliferation assays (CCK-8) and surgical intervention in T2DM mouse models (Roux-en-Y gastric bypass).
Main Results:
- NPAS2 was significantly upregulated in T2DM islet beta cells, correlating with apoptosis.
- NPAS2 demonstrated high diagnostic accuracy for T2DM.
- NPAS2 overexpression increased KANK1 levels; knockdown of NPAS2 and KANK1 enhanced MIN6 cell proliferation.
- Gastric bypass surgery reduced NPAS2 and KANK1 expression in T2DM mice.
Conclusions:
- NPAS2 induces beta cell dysfunction in T2DM by regulating KANK1 expression.
- NPAS2 represents a potential therapeutic target for T2DM.
- Gastric bypass may ameliorate T2DM by downregulating NPAS2 and KANK1.
More Related Videos
Related Concept Videos
Cell Specific Gene Expression
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
Insulin and C-peptide are...
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
cAMP-dependent Protein Kinase Pathways
Insulin Secretory Vesicles
Insulin: Biosynthesis, Chemistry, and Preparation
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...

